Document is current
Any future updates will be listed below
-
Authors
Sanchez, Lise
Viana, Marcus Vinicius Canario
Robert, Veronique
Chain, Florian
Chadi, Sead
Azevedo, Vasco
Mosca, Alexis
Langella, Philippe
Binda, Sylvie
Martín, Rebeca
-
Funding
Funding for this research was provided by:
Université Paris-Saclay
- License Information
-
More Information
Article History
Received: 29 August 2025
Accepted: 31 March 2026
First Online: 14 April 2026
Declarations
:
: L.S. and S.B. are employees of Lallemand Health Solutions. Founders participated in the study design. P.L. reports lecture fee, board membership, or consultancy from Biose, Biostime, Boiron, Bonduelle, BMS, Bromatech, IPSEN, iTaK, Lallemand, Lesaffre, L’Oréal, Mayoli, Merck, Procter and Gamble, Second Genome, Therascience and URGO and is co-founder of Exeliom Biosciences. A.M. is Advisory board member, consultant, and speaker for several companies, including BioGaia, Biocodex, Danone (Nutricia), Nestlé, Havea, PiLeJe, Sodilac, Mead Johnson, and Adare (Dsm-Firmenich). The authors declare no other competing interests.
